2,851
edits
Nicotinamide Mononucleotide (NMN): Difference between revisions
Nicotinamide Mononucleotide (NMN) (view source)
Revision as of 23:10, 2 December 2023
, 2 December 2023→Clinical Trials
| Line 299: | Line 299: | ||
* nonsmokers | * nonsmokers | ||
| | | | ||
* 250 mg of NMN per day for 12 weeks | * 250 mg of NMN per day for 12 weeks significantly increased NAD+ blood levels in healthy males older than 65. | ||
* The supplementation regimen improves walking speed and grip strength in the aged men. | * The supplementation regimen improves walking speed and grip strength in the aged men. | ||
* These findings suggest NMN supplementation may be used to ameliorate age-related muscle deterioration. | * These findings suggest NMN supplementation may be used to ameliorate age-related muscle deterioration. | ||